Pharmaceuticals News

Vancouver, British Columbia--(Newsfile Corp. - May 25, 2022) - Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) ("Nextleaf" or the "Company"), a federally regulated manufacturer and distributor of cannabis vapes and oils, announced today the Jamaica Intellectual Property Office has granted Nextleaf a patent for the Company's foundational process...
Biotechnology, Pharmaceuticals, Cannabis, Cannabis Extractor
2022-05-25 9:15 AM EDT | Nextleaf Solutions Ltd.

Jackson Center, Pennsylvania--(Newsfile Corp. - May 24, 2022) - Halberd Corporation (OTC Pink: HALB) researchers have demonstrated a protocol which allows for the precise level of elimination of a specific targeted cytokine from a homogeneous mixture of two different cytokines in a fluid. Several adverse health conditions are caused...
Biotechnology, Pharmaceuticals, Health
2022-05-24 8:00 AM EDT | Halberd Corp.

Vancouver, British Columbia--(Newsfile Corp. - May 24, 2022) - Nirvana Life Sciences Inc. (CSE: NIRV) (Nirvana or the "Company"), a western Canadian based life sciences company aimed at developing non-addictive chronic pain and relapse preventing products announces that its strategic partners Symeres are licensed to produce large quantities of controlled...
Biotechnology, Pharmaceuticals
2022-05-24 7:32 AM EDT | Nirvana Life Sciences Inc.

Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - May 23, 2022) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) (Neovasc or the Company) today announced that its management team will be participating in the H.C. Wainwright Global Investment Conference to be held May 23-26, 2022. Fred Colen, Neovasc's President and...
Pharmaceuticals, Health
2022-05-23 4:05 PM EDT | Neovasc Inc.

Calgary, Alberta--(Newsfile Corp. - May 19, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) ("Hemostemix" or the "Company") is pleased to announce a non-brokered private placement of up to 15 Million Units priced in the context of the market. Each Unit consists of one common share in the...
Biotechnology, Pharmaceuticals, Health
2022-05-19 4:55 PM EDT | Hemostemix Inc.

Calgary, Alberta--(Newsfile Corp. - May 19, 2022) -   Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is pleased to announce the appointment of Mr. Peter Pavlin, P.Eng. to the position of Vice President Operations.Mr. Pavlin earned his Bachelor of Applied Science and Master of Engineering degrees in...
Biotechnology, Pharmaceuticals, Health
2022-05-19 11:29 AM EDT | Hemostemix Inc.

The Company is issuing a clarification news release at the request of IIROC.Vancouver, British Columbia--(Newsfile Corp. - May 18, 2022) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence" or the "Company"), a Canadian biopharmaceuticals company primarily focused on the development of novel immune-oncology vaccines and drug...
Biotechnology, Pharmaceuticals, Health
2022-05-18 11:30 AM EDT | Defence Therapeutics Inc.

Jackson Center, Pennsylvania--(Newsfile Corp. - May 18, 2022) - Halberd Corporation (OTC Pink: HALB) has engaged the services of mdi Consultants, Inc. (mdi) to assist Halberd in navigating the U.S. Food and Drug Administration's (FDA) complex application and certification processes. mdi will guide Halberd on the FDA application and...
Biotechnology, Pharmaceuticals, Health
2022-05-18 8:00 AM EDT | Halberd Corp.

Vancouver, British Columbia--(Newsfile Corp. - May 17, 2022) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence" or the "Company"), a Canadian biopharmaceuticals company primarily focussed on the development of novel immune-oncology vaccines and drug delivery technologies, is pleased to announce the development of novel dual-acting AccumTM-linked protein...
Biotechnology, Pharmaceuticals, Health
2022-05-17 4:30 PM EDT | Defence Therapeutics Inc.

Cincinnati, Ohio--(Newsfile Corp. - May 17, 2022) - CTI Clinical Trial and Consulting Services (CTI), a global research service provider, will relocate and expand its European laboratory. The new facility, located in Bizkaia Technology Park in Bilbao, Spain, will increase the laboratory footprint by more than 500%. The expanded footprint...
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2022-05-17 4:01 PM EDT | CTI Clinical Trial & Consulting

Vancouver, British Columbia--(Newsfile Corp. - May 17, 2022) - Nirvana Life Sciences Inc. (CSE: NIRV) (Nirvana or the "Company"), a Canadian based life sciences company aimed at developing non-addictive chronic pain and relapse preventing products, is pleased to announce that it has signed a letter of intent with Innovate...
Biotechnology, Pharmaceuticals
2022-05-17 9:00 AM EDT | Nirvana Life Sciences Inc.

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - May 17, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") is pleased to announce that it has filed and obtained a receipt for a final short form base shelf prospectus (the "Base Shelf Prospectus") with the...
Pharmaceuticals, Cannabis, Cannabis Manufacturer, Cannabis Ancillary Service Provider
2022-05-17 2:03 AM EDT | Innocan Pharma Corporation

Net revenue for Q1 2022 was $6.9 millionVIVO continues to pursue its international expansion strategy which now represents >50% of cannabis revenueCanadian Launch of Canna Farms Single-strain Oils, Infused Pre-rolls, Top Cola Signature Series and Fireside CBD Canna Bliss 510 Vape Cartridge and 10 pack CBD ChocolatesHarvest Medicine study on...
Pharmaceuticals, Cannabis, Health
2022-05-16 10:00 PM EDT | VIVO Cannabis Inc.

Bogotá, Colombia--(Newsfile Corp. - May 16, 2022) - Medcolcanna Organics Inc. (CSE: MCCN) ("Medcolcanna", "MCCN" or the "Company"), a leading Canadian and globally integrated medicinal cannabis company with operations in Colombia, is announcing, further to its previous press release dated May 3, 2022 that its audited financial report, CEO and...
Pharmaceuticals, Cannabis
2022-05-16 8:35 PM EDT | Medcolcanna Organics Inc.

Vancouver, British Columbia--(Newsfile Corp. - May 16, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the "Company") is providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 - Management Cease Trade Orders ("NP 12-203").On April 28, 2022, the Company announced...
Pharmaceuticals, Cannabis, Health, Cannabis Manufacturer
2022-05-16 4:05 PM EDT | Emerald Health Therapeutics, Inc.

Calgary, Alberta--(Newsfile Corp. - May 16, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is pleased to announce Mr. Richard ("Rick") Groome has joined Hemostemix as a special advisor to the CEO, focused on completing a series of financing transactions. Over the last three decades...
Biotechnology, Pharmaceuticals, Health
2022-05-16 9:49 AM EDT | Hemostemix Inc.

Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - May 16, 2022) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") announced today that it has received written notification from the Nasdaq Stock Market LLC (the "Nasdaq") informing the Company that it has regained compliance with the minimum bid...
Pharmaceuticals, Health
2022-05-16 9:05 AM EDT | Neovasc Inc.

Panel discussion will focus on the successful translation of NervGen's lead compound, NVG-291, from animals to humans Leading spinal cord injury experts on the panel include Drs. Jerry Silver, Monica Perez and James GuestNervGen will also present at the International Investment Forum Vancouver, British Columbia--(Newsfile Corp. - May 16, 2022)...
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2022-05-16 8:30 AM EDT | NervGen Pharma Corp.

Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - May 12, 2022) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") today reported financial results for the quarter ended March 31, 2022.Recent HighlightsAchieved Q1 revenue of approximately $611,000, an increase of 35% over the same period in 2021, delivering...
Pharmaceuticals, Health
2022-05-12 4:05 PM EDT | Neovasc Inc.